2289 |
Updating the Overview of the Worldwide Evidences |
Osamu Iida |
May. 12. 14 |
2288 |
Strategy for Success in CLI - Common Challenging Scenarios and Solutions |
Jae-Hwan Lee |
May. 12. 14 |
2287 |
Overcoming the Challenges - Various Approaches & Strategies for Super Complex Lesions |
Kazushi Urasawa |
May. 12. 14 |
2286 |
Renal Denervation Highlights and Review of HTN-3 Results |
Krishna Rocha-Singh |
May. 12. 14 |
2285 |
Insights from the RESOLUTE Asia Trial – Part II: 2-year Outcomes of the 38mm Cohort |
Jin-Ok Jeong |
May. 12. 14 |
2284 |
Insights from the RESOLUTE Asia Trial – Part I: Preview to the Dual Vessel Cohort |
Robaayah Zambahari |
May. 12. 14 |
2283 |
Future Technologies for Interventional Therapy |
Josiah N. Wilcox |
May. 12. 14 |
2282 |
The Economic Value of DEB in Femoro-popliteal Revascularization |
Michael R. Jaff |
May. 12. 14 |
2281 |
DEB Lesson from Real Practice: Tips & Tricks for Optimal Usage |
Antonio Micari |
May. 12. 14 |
2280 |
DEB in Challenging Lesion (CTO, Ca++) |
Gian Battista Danzi |
May. 12. 14 |